New drug could help protect kidneys in autoimmune diseases
NCT ID NCT06983028
First seen Jan 23, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study tests a drug called atacicept in 200 adults and teens with several autoimmune kidney diseases, including IgA nephropathy and focal segmental glomerulosclerosis. The goal is to see if it safely reduces protein in the urine and helps preserve kidney function. Participants must be on stable standard treatments and weigh at least 40 kg.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vera Therapeutics
RECRUITINGBrisbane, California, 94005, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.